HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroepidemiology of novel influenza A (H1N1) infection among HIV-infected patients in the era of highly active antiretroviral therapy.

AbstractBACKGROUND:
The seroprevalence and seroincidence of novel influenza A infection among HIV-infected patients, who were believed to have more severe outcomes than healthy individuals, are rarely investigated in the era of highly active antiretroviral therapy (HAART). Our aim was to determine the seroprevalence and seroincidence of novel influenza A infection among HIV-infected patients in Taiwan.
METHODS:
Between September and November 2009, before the implementation of a nationwide vaccination for novel influenza A in Taiwan, 931 HIV-infected patients and 566 persons seeking voluntary counseling and testing (VCT) for HIV infection at our university hospital were enrolled in this study. Antibody responses to novel influenza A were determined using a hemagglutination-inhibition (HI) assay.
RESULTS:
HIV-infected patients had a significantly lower seroprevalence of novel influenza A infection than VCT clients (14.7% vs. 33.9%, p < 0.001). The seroincidence of novel influenza A infection among HIV-infected patients was 9.4% (95% confidence interval [CI]: 7.6-11.4). On the multivariate analysis, heterosexual (odds ratio [OR]: 1.89; 95% CI: 1.105-3.227) and baseline HI titer (OR: 1.02; 95% CI: 1.001-1.038) were significantly associated with seroconversion to novel influenza A virus.
CONCLUSION:
HIV-infected patients demonstrated a lower seroprevalence of novel influenza A infection than HIV-uninfected patients in Taiwan in the HAART era. Among HIV-infected patients, seroconversion to novel influenza A virus, which was infrequent during the 2009 influenza epidemic, was associated with heterosexual behavior and baseline HI titer.
AuthorsChien-Ching Hung, Tai-Ling Zhao, Hsin-Yun Sun, Yi-Fang Yang, Yi-Ching Su, Shu-Fang Chang, Wen-Chun Liu, Cheng-Hsin Wu, Sui-Yuan Chang, Shan-Chwen Chang
JournalJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect) Vol. 46 Issue 3 Pg. 151-7 (Jun 2013) ISSN: 1995-9133 [Electronic] England
PMID22579505 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012. Published by Elsevier B.V.
Chemical References
  • Antibodies, Viral
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (blood)
  • Antiretroviral Therapy, Highly Active (methods)
  • Child
  • Child, Preschool
  • Female
  • HIV Infections (complications, drug therapy)
  • Hemagglutination Inhibition Tests
  • Hospitals, University
  • Humans
  • Incidence
  • Infant
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza, Human (epidemiology, immunology)
  • Male
  • Middle Aged
  • Seroepidemiologic Studies
  • Taiwan
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: